NCT06769646View on ClinicalTrials.gov

SPRING - Assess the Clinical Care Pathway of Population With T2D and CKD in Four European Countries Using Real-world Data

CompletedOBSERVATIONAL

Enrollment

110,074

Participants

Timeline

Start Date

December 2, 2024

Primary Completion Date

January 6, 2025

Study Completion Date

January 6, 2025

Conditions

Type 2 Diabetes Mellitus (T2D) and Chronic Kidney Disease (CKD)

Interventions

OTHER

No tretament given

No treatment given

Trial Locations (1)

Unknown

Novo Nordisk Investigational site, Bangalore

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY